In the case of prostate cancer, over 15 years, outcomes were surprisingly similar for three groups: a prostatectomy group, a radiotherapy group, and a nontreatment group under active monitoring. The study’s authors found that prostate cancer-specific mortality was relatively low regardless of the approach taken: treatment or nontreatment.